88IV - Public company info - 3D Medicines Inc.

Input the stock code or the company name

3D Medicines Inc., 01244.HK - Cash Flow	2021-12	2020-12
Net Cash Flow from Operating Activities	-377,079	-278,329
Net Cash Flow from Return on Investments & Servicing of Finance	3,954	-15,923
Interest Received	5,482	1,610
Interest Paid	-1,528	-17,533
Dividend Received	0	0
Dividend Paid	0	0
Others	0	0
Taxes (Paid) / Refunded	0	0
Net Cash Flow from Investing Activities	-104,353	-22,090
Additions to Fixed Assets	-55,364	-11,147
Disposal of Fixed Assets	0	4
Increase in Investments	-100,000	-11,118
Decrease in Investments	50,424	6,171
Net Cash Flow with Related Parties	332,780	-11,948
Others	-332,193	5,948
Net Cash Flow before Financing Activities	-477,478	-316,342
Net Cash Flow from Financing Activities	841,610	624,920
New Loans	0	3,522
Loans Repayment	-9,254	-126,173
Fixed Income/Debt Instruments	0	0
Repayment of Fixed Income/Debt Instruments	0	0
Equity Financing	1,620,422	783,818
Net Cash Flow with Related Parties	332,780	-11,948
Others	-1,102,338	-24,299
Increase(Decrease) in Cash & Cash Equivalents	364,132	308,578
Cash & Cash Equivalents at Beginning of Year	414,261	112,156
Net Cash Flow due to Change in Exchange Rate/Others	-4,087	-6,473
Cash & Cash Equivalents at End of Year	774,306	414,261
Currency	Renminbi	Renminbi
Unit
Auditor's Opinion	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - 3D Medicines Inc. , 01244.HK